detalle del documento
IDENTIFICACIÓN

oai:arXiv.org:2403.18421

Tema
Computer Science - Computation and... Computer Science - Artificial Inte...
Autor
Bolton, Elliot Venigalla, Abhinav Yasunaga, Michihiro Hall, David Xiong, Betty Lee, Tony Daneshjou, Roxana Frankle, Jonathan Liang, Percy Carbin, Michael Manning, Christopher D.
Categoría

Computer Science

Año

2024

fecha de cotización

3/4/2024

Palabras clave
trained models
Métrico

Resumen

Models such as GPT-4 and Med-PaLM 2 have demonstrated impressive performance on a wide variety of biomedical NLP tasks.

However, these models have hundreds of billions of parameters, are computationally expensive to run, require users to send their input data over the internet, and are trained on unknown data sources.

Can smaller, more targeted models compete?

To address this question, we build and release BioMedLM, a 2.7 billion parameter GPT-style autoregressive model trained exclusively on PubMed abstracts and full articles.

When fine-tuned, BioMedLM can produce strong multiple-choice biomedical question-answering results competitive with much larger models, such as achieving a score of 57.3% on MedMCQA (dev) and 69.0% on the MMLU Medical Genetics exam.

BioMedLM can also be fine-tuned to produce useful answers to patient questions on medical topics.

This demonstrates that smaller models can potentially serve as transparent, privacy-preserving, economical and environmentally friendly foundations for particular NLP applications, such as in biomedicine.

The model is available on the Hugging Face Hub: https://huggingface.co/stanford-crfm/BioMedLM.

;Comment: 23 pages

Bolton, Elliot,Venigalla, Abhinav,Yasunaga, Michihiro,Hall, David,Xiong, Betty,Lee, Tony,Daneshjou, Roxana,Frankle, Jonathan,Liang, Percy,Carbin, Michael,Manning, Christopher D., 2024, BioMedLM: A 2.7B Parameter Language Model Trained On Biomedical Text

Documento

Abrir

Compartir

Fuente

Artículos recomendados por ES/IODE IA

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
agphd1 subtypes replication hykk squamous cell gene carcinoma causal targets mendelian randomization cancer analysis